Healthcare
Live Price
Offline$3.00
+0.00% today
1Y Change
+31.00%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 252 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ping An Healthcare and Technology Company Limited (PIAHY) is a Healthcare stock with a market cap of $19.91B and listed on OTC. The stock last traded around $3.00 and up 31.0% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +10.6%, EPS growth of +150.3%, a dividend yield of 0.0%. What stands out right now is revenue +10.6%, EPS +150.3%, free cash flow +501.2% with operating margin 1.8% and ROIC 1.0%. Valuation already assumes a fairly strong business story at P/E 53.0 and price/sales 3.7. Stock Foundry combines PIAHY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PIAHY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PIAHY Max Drawdown
-45.45%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PIAHY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$7.3B
+18.2% YoY
FY Net Income
-$1.5B
-141.8% YoY
Free Cash Flow
-$1.5B
-76.6% YoY
Revenue Growth
+10.6%
EPS Growth
+150.3%
Gross Margin
32.4%
Net Margin
6.9%
Income statement
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.3B | 4.8B | 4.7B | 6.2B | 7.3B |
| Gross Profit | 1.7B | 1.5B | 1.5B | 1.7B | 1.7B |
| Operating Income | 182M | -89M | -575M | -726M | -1.6B |
| EBITDA | 255M | 193M | -164M | -1.0B | -1.8B |
| Net Income | 369M | 81M | -323M | -636M | -1.5B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.4B | 2.0B | 1.9B | 3.7B | 3.1B |
| Total Assets | 13.2B | 16.8B | 16.5B | 17.1B | 17.9B |
| Total Liabilities | 3.3B | 13.2B | 3.3B | 3.7B | 3.8B |
| Shareholder Equity | 9.9B | 3.6B | 13.3B | 13.5B | 14.1B |
| Total Debt | 40M | 45M | 94M | 176M | 201M |
| Net Debt | -2.4B | -2.0B | -1.8B | -3.5B | -2.9B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1.4B
-73.1% YoY
Capital Expenditures
89M
-158.9% YoY
Free Cash Flow
1.5B
-76.6% YoY
Key ratios
Gross Margin
32.4%
Operating Margin
1.8%
Net Margin
6.9%
ROE
3.8%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.